Cargando…

An 8-Hydroxy-Quinoline Derivative Protects Against Lipopolysaccharide-Induced Lethality in Endotoxemia by Inhibiting HMGB1-Mediated Caspase-11 Signaling

Sepsis, an inflammatory syndrome secondary to infection, is the leading cause of in-hospital lethality. It is evidenced that LPS, the major pathological component of the Gram-negative bacteria membrane, predominantly contributes to the pathogenesis of sepsis. Cytoplasmic lipopolysaccharide (LPS) can...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiangyu, Shi, Jian, Li, Zhaozheng, Li, Ling, Zhang, Rui, Bai, Yang, Li, Junmei, Liang, Fang, Tang, Yiting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176522/
https://www.ncbi.nlm.nih.gov/pubmed/34093202
http://dx.doi.org/10.3389/fphar.2021.673818
_version_ 1783703271838318592
author Wang, Xiangyu
Shi, Jian
Li, Zhaozheng
Li, Ling
Zhang, Rui
Bai, Yang
Li, Junmei
Liang, Fang
Tang, Yiting
author_facet Wang, Xiangyu
Shi, Jian
Li, Zhaozheng
Li, Ling
Zhang, Rui
Bai, Yang
Li, Junmei
Liang, Fang
Tang, Yiting
author_sort Wang, Xiangyu
collection PubMed
description Sepsis, an inflammatory syndrome secondary to infection, is the leading cause of in-hospital lethality. It is evidenced that LPS, the major pathological component of the Gram-negative bacteria membrane, predominantly contributes to the pathogenesis of sepsis. Cytoplasmic lipopolysaccharide (LPS) can be sensed by the noncanonical inflammasome and triggers the oligomerization of caspase-11, resulting in pyroptosis and lethal immune responses in sepsis. A previous study has shown that hepatocyte-released high mobility group box 1 (HMGB1) mediates caspase-11–dependent lethality in sepsis by delivering extracellular LPS into the cytosol. Here, we established a phenotypic screening system using recombinant HMGB1 plus LPS in mouse peritoneal macrophages, identifying a novel 8-hydroxyquinoline derivative named 7-[phenyl (pyridin-2-ylamino) methyl] quinolin-8-ol (8-ol, NSC84094) that can specifically inhibit HMGB1-mediated caspase-11 signaling. 8-ol targets directly to HMGB1 and changes the secondary conformation, consequently disrupting the interaction between LPS and HMGB1 and inhibiting the HMGB1-mediated delivery of LPS into the cytosol. Intervention of 8-ol significantly reduced the release of IL-1α and IL-1β and protected against caspase-11–mediated organ injury and lethality in endotoxemic mice. Thus, this study clearly suggests that the HMGB1–caspase-11 pathway is a potential drug target in lethal immune disorders and might open a new avenue in the treatment of sepsis.
format Online
Article
Text
id pubmed-8176522
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81765222021-06-05 An 8-Hydroxy-Quinoline Derivative Protects Against Lipopolysaccharide-Induced Lethality in Endotoxemia by Inhibiting HMGB1-Mediated Caspase-11 Signaling Wang, Xiangyu Shi, Jian Li, Zhaozheng Li, Ling Zhang, Rui Bai, Yang Li, Junmei Liang, Fang Tang, Yiting Front Pharmacol Pharmacology Sepsis, an inflammatory syndrome secondary to infection, is the leading cause of in-hospital lethality. It is evidenced that LPS, the major pathological component of the Gram-negative bacteria membrane, predominantly contributes to the pathogenesis of sepsis. Cytoplasmic lipopolysaccharide (LPS) can be sensed by the noncanonical inflammasome and triggers the oligomerization of caspase-11, resulting in pyroptosis and lethal immune responses in sepsis. A previous study has shown that hepatocyte-released high mobility group box 1 (HMGB1) mediates caspase-11–dependent lethality in sepsis by delivering extracellular LPS into the cytosol. Here, we established a phenotypic screening system using recombinant HMGB1 plus LPS in mouse peritoneal macrophages, identifying a novel 8-hydroxyquinoline derivative named 7-[phenyl (pyridin-2-ylamino) methyl] quinolin-8-ol (8-ol, NSC84094) that can specifically inhibit HMGB1-mediated caspase-11 signaling. 8-ol targets directly to HMGB1 and changes the secondary conformation, consequently disrupting the interaction between LPS and HMGB1 and inhibiting the HMGB1-mediated delivery of LPS into the cytosol. Intervention of 8-ol significantly reduced the release of IL-1α and IL-1β and protected against caspase-11–mediated organ injury and lethality in endotoxemic mice. Thus, this study clearly suggests that the HMGB1–caspase-11 pathway is a potential drug target in lethal immune disorders and might open a new avenue in the treatment of sepsis. Frontiers Media S.A. 2021-05-21 /pmc/articles/PMC8176522/ /pubmed/34093202 http://dx.doi.org/10.3389/fphar.2021.673818 Text en Copyright © 2021 Wang, Shi, Li, Li, Zhang, Bai, Li, Liang and Tang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wang, Xiangyu
Shi, Jian
Li, Zhaozheng
Li, Ling
Zhang, Rui
Bai, Yang
Li, Junmei
Liang, Fang
Tang, Yiting
An 8-Hydroxy-Quinoline Derivative Protects Against Lipopolysaccharide-Induced Lethality in Endotoxemia by Inhibiting HMGB1-Mediated Caspase-11 Signaling
title An 8-Hydroxy-Quinoline Derivative Protects Against Lipopolysaccharide-Induced Lethality in Endotoxemia by Inhibiting HMGB1-Mediated Caspase-11 Signaling
title_full An 8-Hydroxy-Quinoline Derivative Protects Against Lipopolysaccharide-Induced Lethality in Endotoxemia by Inhibiting HMGB1-Mediated Caspase-11 Signaling
title_fullStr An 8-Hydroxy-Quinoline Derivative Protects Against Lipopolysaccharide-Induced Lethality in Endotoxemia by Inhibiting HMGB1-Mediated Caspase-11 Signaling
title_full_unstemmed An 8-Hydroxy-Quinoline Derivative Protects Against Lipopolysaccharide-Induced Lethality in Endotoxemia by Inhibiting HMGB1-Mediated Caspase-11 Signaling
title_short An 8-Hydroxy-Quinoline Derivative Protects Against Lipopolysaccharide-Induced Lethality in Endotoxemia by Inhibiting HMGB1-Mediated Caspase-11 Signaling
title_sort 8-hydroxy-quinoline derivative protects against lipopolysaccharide-induced lethality in endotoxemia by inhibiting hmgb1-mediated caspase-11 signaling
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176522/
https://www.ncbi.nlm.nih.gov/pubmed/34093202
http://dx.doi.org/10.3389/fphar.2021.673818
work_keys_str_mv AT wangxiangyu an8hydroxyquinolinederivativeprotectsagainstlipopolysaccharideinducedlethalityinendotoxemiabyinhibitinghmgb1mediatedcaspase11signaling
AT shijian an8hydroxyquinolinederivativeprotectsagainstlipopolysaccharideinducedlethalityinendotoxemiabyinhibitinghmgb1mediatedcaspase11signaling
AT lizhaozheng an8hydroxyquinolinederivativeprotectsagainstlipopolysaccharideinducedlethalityinendotoxemiabyinhibitinghmgb1mediatedcaspase11signaling
AT liling an8hydroxyquinolinederivativeprotectsagainstlipopolysaccharideinducedlethalityinendotoxemiabyinhibitinghmgb1mediatedcaspase11signaling
AT zhangrui an8hydroxyquinolinederivativeprotectsagainstlipopolysaccharideinducedlethalityinendotoxemiabyinhibitinghmgb1mediatedcaspase11signaling
AT baiyang an8hydroxyquinolinederivativeprotectsagainstlipopolysaccharideinducedlethalityinendotoxemiabyinhibitinghmgb1mediatedcaspase11signaling
AT lijunmei an8hydroxyquinolinederivativeprotectsagainstlipopolysaccharideinducedlethalityinendotoxemiabyinhibitinghmgb1mediatedcaspase11signaling
AT liangfang an8hydroxyquinolinederivativeprotectsagainstlipopolysaccharideinducedlethalityinendotoxemiabyinhibitinghmgb1mediatedcaspase11signaling
AT tangyiting an8hydroxyquinolinederivativeprotectsagainstlipopolysaccharideinducedlethalityinendotoxemiabyinhibitinghmgb1mediatedcaspase11signaling
AT wangxiangyu 8hydroxyquinolinederivativeprotectsagainstlipopolysaccharideinducedlethalityinendotoxemiabyinhibitinghmgb1mediatedcaspase11signaling
AT shijian 8hydroxyquinolinederivativeprotectsagainstlipopolysaccharideinducedlethalityinendotoxemiabyinhibitinghmgb1mediatedcaspase11signaling
AT lizhaozheng 8hydroxyquinolinederivativeprotectsagainstlipopolysaccharideinducedlethalityinendotoxemiabyinhibitinghmgb1mediatedcaspase11signaling
AT liling 8hydroxyquinolinederivativeprotectsagainstlipopolysaccharideinducedlethalityinendotoxemiabyinhibitinghmgb1mediatedcaspase11signaling
AT zhangrui 8hydroxyquinolinederivativeprotectsagainstlipopolysaccharideinducedlethalityinendotoxemiabyinhibitinghmgb1mediatedcaspase11signaling
AT baiyang 8hydroxyquinolinederivativeprotectsagainstlipopolysaccharideinducedlethalityinendotoxemiabyinhibitinghmgb1mediatedcaspase11signaling
AT lijunmei 8hydroxyquinolinederivativeprotectsagainstlipopolysaccharideinducedlethalityinendotoxemiabyinhibitinghmgb1mediatedcaspase11signaling
AT liangfang 8hydroxyquinolinederivativeprotectsagainstlipopolysaccharideinducedlethalityinendotoxemiabyinhibitinghmgb1mediatedcaspase11signaling
AT tangyiting 8hydroxyquinolinederivativeprotectsagainstlipopolysaccharideinducedlethalityinendotoxemiabyinhibitinghmgb1mediatedcaspase11signaling